✦ LIBER ✦

Secondary chemotherapy of advanced breast cancer

✍ Scribed by Ira S. Goldenberg; C. A. McMahan; George C. Escher; Herbert Volk; Fred J. Ansfield; Kenneth B. Olson

Publisher: John Wiley and Sons
Year: 1973
Tongue: English
Weight: 255 KB
Volume: 31
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(197303)31:3<660::aid-cncr2820310326>3.0.co;2-u

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neoadjuvant chemotherapy in locally adva

Neoadjuvant chemotherapy in locally advanced breast cancer

✍ Singh, Gurpreet; Singh, Deepinder P.; Gupta, Devender; Muralikrishna, Bhavaraju 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 403 KB 👁 1 views

Thirty-eight patients with locally advanced breast cancer (Stage HI) were treated over a 3-year period. All patients initially received two cycles of CMF (cyclophosphamide, 100 mg/m2 p.0. dl-14; methotrexate 40mg/m2 intravenously (iv), d l and d8., 5 Fluorouracil 500 mg/m2 iv d l and d8). They were

Management of locally advanced and disse

Management of locally advanced and disseminated breast cancer—chemotherapy

✍ Harry F. Bisel 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 468 KB 👁 1 views

Adjuvant chemotherapy of breast cancer

✍ Richard G. Cooper; James F. Holland; Oliver Glidewell 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 482 KB 👁 1 views

One hundred women with primary breast cancer with 4 or more metastatic axillary nodes were treated for 9 months postoperatively with vincristine, prednisone, cyclophosphamide, methotrexate, and fluorouracil (VPCMF). Sixty-five women have been observed for a minimum of 5 years or until failure and t

Estrogen receptors and responsiveness of

Estrogen receptors and responsiveness of advanced breast cancer to chemotherapy

✍ Bohumil A. Samal; Samuel C. Brooks; Glen Cummings; Luis Franco; Ervin A. Hire; S 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 278 KB 👁 2 views

We reviewed 89 patients with disseminated breast cancer who had at least one valid estrogen receptor (ER) assay and who underwent one or several trials of chemotherapy. The responses were assessed by two independent extramural reviewers. Of the 89 patients, 81 were evaluable; 28 of 36 (77.8%) ER-pos

Mitomycin C and vinblastine chemotherapy

Mitomycin C and vinblastine chemotherapy for advanced breast cancer

✍ P. H. Konits; J. Aisner; D. A. Van Echo; K. Lichtenfeld; P. H. Wiernik 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 395 KB 👁 1 views

Developments in chemotherapy of breast c

Developments in chemotherapy of breast cancer

✍ Gabriel N. Hortobagyi 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB 👁 2 views